Hibor 3.500 ui anti xa/0,2 ml soluciÓn inyectable en jeringas precargadas

Label: information for the user

HIBOR 3.500 UI anti Xa/0.2 ml

Injectable solution in preloaded syringes

Bemiparin sodium

Read this label carefully before starting to use this medication, as it contains important information for you.

• Keep this label, as you may need to read it again.
• If you have any questions, consult your doctor, pharmacist, or nurse.
• This medication has been prescribed only for you and should not be given to others, even if they have the same symptoms as you, as it may harm them.
• If you experience any adverse effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this label. See section 4

The active ingredient of HIBOR is bemiparin sodium, which belongs to a group of medications called anticoagulants. These medications help prevent blood from clotting in veins.

HIBOR 3.500 UI is used to: prevent blood clots (for example, in leg veins and/or lung veins) that may occur in patients undergoing orthopedic surgery, in patients not undergoing surgical intervention but who have a high risk of developing clots and in patients who have previously experienced clots and have transient risk factors.

It is also used to prevent clot formation in the extracorporeal circulation circuit during hemodialysis.

Do not use HIBOR 3.500 UI

• If you are allergic to benzyl alcohol, heparin sodium, or a similar product (such as enoxaparin, dalteparin, or nadroparin)or to any of the other components of this medication (listed in section 6).
• If you have had an allergic reaction after being treated with a medication that contains heparin.
• If you are allergic to any porcine-derived substance.
• If you have Heparin-Induced Thrombocytopenia (HIT), a disease that causes a significant decrease in your platelet count (or, if as a result of HIT, you suffer from another disease called Disseminated Intravascular Coagulation (DIC), in which your platelets would clump if you used HIBOR).
• If you have endocarditis (inflammation of the heart walls and heart valves).
• If you have a condition that causes excessive bleeding.
• If you have a severe liver or pancreas disorder.

• If you have suffered internal organ damage that may pose a high risk of internal bleeding (e.g., active stomach ulcers, cerebral aneurysms [inflammation of the walls of the brain arteries] or brain tumors).
• If you have had a cerebral hemorrhage.
• If you have had or are having a brain, spinal cord, eye, or ear injury in the past 2 months.

• If you are using HIBOR, you will not be able to receive epidural or spinal anesthesia (an injected anesthetic in the spinal cord) because it could be hazardous. Therefore, ensure that your doctor knows you are using HIBOR before any operation.

Warnings and precautionsConsult your doctor before starting to use HIBOR 3.500 UI

• If you have liver disease.
• If you have kidney disease.Your doctor may consider a special follow-up. If your disease is severe, your doctor may consider a dose adjustment.
• If you have high blood pressure and/or uncontrolled blood pressure.
• If you have had a stomach ulcer that is no longer active.
• If you have thrombocytopenia, a disease in which there are fewer platelets than normal in the blood, causing bruising and easy bleeding.
• If you have kidney stones or bladder stones.
• If you have a condition that causes you to bleed easily.
• If you have eye problems due to blood vessel problems.
• If you have diabetes.
• If your blood potassium levels have been shown to be elevated by your tests.
• Ensure that your doctor knows you are using HIBOR if you are to have a lumbar puncture (a needle prick at the lowest part of the spine for analysis).

Using HIBOR 3.500 UI with other medications

Inform your doctor if you are using, have used recently, or may need to use any other medication.

• Any medication that is injected into the muscle, as these injections should be avoided while on HIBOR treatment.
• Other anticoagulants such as warfarin and/or acenocoumarol (vitamin K antagonists), to treat and/or prevent blood clots.
• Non-steroidal anti-inflammatory drugs, such as ibuprofen, for example, for arthritis.
• Corticosteroids such as prednisolone, to treat inflammatory diseases, such as arthritis.
• Platelet inhibitors, such as aspirin, ticlopidine, or clopidogrel, to prevent blood clots.
• Medications that may increase blood potassium levels, such as some diuretics and antihypertensives (used to reduce blood pressure).
• Medications to increase blood volume, such as dextran.
• A heart problem medication called nitroglycerin.

Special analyses you may need

• Some patients may need to have their platelet count in the blood monitored. Your doctor will decide if it is necessary and when (e.g., before starting treatment, the first day of treatment, subsequently every 3 or 4 days until treatment is completed).
• If you have certain diseases (diabetes, kidney disease) or if you are taking medications to prevent potassium loss, your doctor may monitor your potassium levels in the blood.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Driving and operating machinery

HIBOR does not affect your ability to drive and operate machinery.

Follow exactly the administration instructions of this medication as indicated by your doctor, pharmacist, or nurse. If in doubt, ask your doctor, pharmacist, or nurse.

HIBOR is injected under the skin, usually in a skin fold on one side of the waist (abdomen) or on the upper part of the hip. Normally, your doctor or nurse will administer the injection in the hospital. You may need to continue receiving HIBOR when you return home.

This medication should never be injected into a muscle or mixed with any other injection. It is usually administered once a day.

Your doctor will tell you how long you should receive this medication.

If your doctor has told you that you can administer this medication yourself, follow your doctor's instructions carefully (See section “How do I inject HIBOR?”).

The recommended dose is:

Adults (18-64 years)

Undergoing orthopedic surgery:

• You will receive a dose of the product (the contents of a syringe = 3,500 UI) before or after your operation.
• In the following days, you will receive a daily dose of the product (the contents of a syringe = 3,500 UI).

At high risk of developing blood clots:

• You will receive a daily dose of the product (the contents of a syringe = 3,500 UI), for the period established by your doctor.

Who have had blood clots previously:

• You will receive a daily dose of the product (the contents of a syringe = 3,500 UI), for a maximum period of 3 months.

UI: The potency of this medication is described in international units of anti-Xa activity.

Seniors (65 years and older)

They usually receive the same dose as other adult patients. If you have liver or kidney problems, please inform your doctor, as they may decide to monitor you closely.If your kidney disease is mild or moderate, no dose adjustment is necessary.

Patients with renal insufficiency

If your kidney disease is severe, your doctor may consider a dose adjustment.

If your kidney disease is mild or moderate, no dose adjustment is necessary.

Patients with hepatic insufficiency

There are not enough data for your doctor to recommend a dose adjustment.

Use in children and adolescents

HIBOR is not recommended for children.

How do I inject HIBOR?

HIBOR should never be injected into a muscle as it may cause bleeding within the muscle. Before administering your first injection, you should receive instructions on the correct way to use this medication and on the correct technique for self-injection. These instructions should be given by a qualified healthcare professional.

You should follow these steps:

• Wash your hands thoroughly and sit or lie down in a comfortable position.
• Choose an area of the waist that is at least 5 centimeters away from the navel and any scars or bruises, and clean the skin in that area thoroughly.
• Use a different site each day for the injection, for example, first on the left side and the next time on the right.
• Remove the cap that covers the needle of the HIBOR syringe.

• To keep the needle sterile, make sure it does not touch anything.
• The pre-loaded syringe is already ready for use.
• Before the injection, do not push the plunger to remove air bubbles, as you may lose medication.

• Hold the syringe with one hand and with the other, using your index and middle fingers, take a pinch of the skin you cleaned to form a fold.
• Insert the entire needle into the skin fold, keeping the syringe as upright as possible on the surface of the body, at a 90-degree angle.
• Push the plunger, making sure to keep the skin fold in the same position until the plunger is fully down.

• Withdraw the syringe from the injection site, keeping your finger on the plunger and the syringe upright. Release the skin fold.

• For syringes with a safety device:Point the needle away from you and anyone present, activate the safety system by pressing firmly on the plunger. The protective cover will automatically cover the needle, and you will hear a audible click that confirms the activation of the protector.

• Immediately dispose of the syringe by throwing it away in the nearest sharps container (with the needle pointing in), close the container tightly and place it out of reach of children.

Warnings:

• The safety system can only be activated once the syringe is empty.
• The activation of the safety system should only be done after removing the needle from the patient's skin.
• Do not reuse the needle protector after injection.
• Activation of the safety system may splash a small amount of liquid. For your maximum safety, activate the safety system pointing it downwards and away from you and anyone present.

• Do not rub the skin where the injection was given. This will help prevent bruising.

If you think the effect of HIBOR 3,500 UI is too strong (for example, because you experience unexpected bleeding) or too weak (for example, because the dose does not seem to be working), inform your doctor or pharmacist.

If you use more HIBOR 3,500 UI than you should

This may cause bleeding. In this case, consult your doctor immediately or go to the nearest hospital emergency department with this leaflet.

In case of overdose or accidental administration, call the Toxicology Information Service. Phone 91 562 04 20, indicating the medication and the amount administered.

If you forget to use HIBOR 3,500 UI

Do not use a double dose to make up for the missed doses. If this happens, you should consult your doctor as soon as possible to tell you what to do.

If you interrupt treatment with HIBOR

Always consult your doctor before stopping this medication.

If you have any other questions about the use of this product, ask your doctor or pharmacist.

Like all medicines, this medicine may cause side effects, although not everyone will experience them.

Stop using HIBOR and consult your doctor or nurse immediately (or go to the nearest hospital emergency service), if you experience any of the following side effects:

Frequent(may affect between 1 and 10 in every 100 patients):

• Unusual or unexpected bleeding, for example, blood in the urine or stool, which may cause hemorrhagic anemia.

Rare(may affect between 1 and 10 in every 1,000 patients):

• Severe decrease in platelet count (Type II thrombocytopenia), which may lead to bruising, bleeding gums, nose, and mouth, and rashes.
• Damage to the skin (necrosis) at injection sites.
• If you have had a lumbar puncture or have received epidural or spinal anesthesia, HIBOR may cause bleeding in the spinal cord and the formation of hematomas. This could cause weakness or numbness in the legs and lower body and/or incontinence of stool and urine. These hematomas may cause varying degrees of disability, including prolonged or permanent paralysis. If this happens, stop using HIBOR 3,500 UI and inform your doctor or nurse immediately.
• Severe allergic reactions (body temperature rise, tremor, difficulty breathing, vocal cord swelling, dizziness, sweating, urticaria, rash, itching, low blood pressure, hot flashes, redness, syncope, bronchial constriction, laryngeal swelling).

Other side effects:

Very frequent (affect more than 1 in 10 patients):

• Bruising, skin spots, itching, and some pain in the areas where the medicine was injected.

Frequent (may affect between 1 and 10 in every 100 patients):

• A mild and transient increase in certain liver enzymes (transaminases) that may appear in blood tests.

Infrequent (may affect at least 10 in every 1,000 patients):

• Mild allergic reactions on the skin (hives, skin rash, urticaria, pruritus, papules).
• Mild and transient decrease in platelet count (Type I thrombocytopenia) that may appear in blood tests.

Unknown frequency (cannot be estimated from available data):

• Hyperkalemia (elevated potassium levels in the blood).
• Bone fragility (osteoporosis) associated with prolonged use of heparin treatment.

Reporting of side effects:

If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:https://www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.

Keep this medication out of sight and reach of children.

Do not store at a temperature above 86°F (30°C). Do not freeze.

Do not usethis medicationif you observe:

• That theprotective packagingisopen.
• That the protective packaging isdamaged.
• That the medication contained in the syringe iscloudy.
• Small particles in the medication.

Once the blister containing the syringe is opened, the medication must be used immediately.

Expiration Date

Do not use this medication after the expiration date that appears on the packaging after CAD.

The expiration date is the last day of the month indicated.

Disposal

This medication is presented insyringes for single use.

Dispose of used syringes in a hazardous waste container.

Do not store them after use.

Medications should not be thrown away through the drains or in the trash. Deposit the packaging and unused medications at the SIGRE point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and unused medications. In this way, you will help protect the environment.

Composition of HIBOR 3.500 UI

The active ingredient is: Sodium Bemiparin 3.500 UI.

The other components are: Water for injection.

Appearance of the product and contents of the package

The medication contained in the syringes is a transparent, colorless or slightly yellowish solution, without visible particles.

HIBOR 3.500 UI is available in boxes of 2, 10, 30, and 50 preloaded syringes. Each syringe contains 0.2 ml of solution. Each 0.2 ml syringe provides a dose of sodium bemiparin of 3.500 UI.

Holder of the marketing authorization and responsible for manufacturing

Holder of the marketing authorization

LABORATORIOS FARMACÉUTICOS ROVI, S.A.

C/ Julián Camarillo, 35

28037 MADRID

Responsible for manufacturing

ROVI Pharma Industrial Services, S.A.

C/ Julián Camarillo, 35

28037 MADRID

LABORATORIOS FARMACÉUTICOS ROVI, S.A.

C/ Julián Camarillo, 35

28037 MADRID

Last review date of this leaflet: 05/2023

The detailed information of this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/